U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C28H24ClNO6
Molecular Weight 505.946
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-CARBOXY-2-PHENYLETHYL 1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOLE-3-ACETATE

SMILES

COC1=CC2=C(C=C1)N(C(=O)C3=CC=C(Cl)C=C3)C(C)=C2CC(=O)OCC(C(O)=O)C4=CC=CC=C4

InChI

InChIKey=UCCJWNPWWPJKGL-UHFFFAOYSA-N
InChI=1S/C28H24ClNO6/c1-17-22(15-26(31)36-16-24(28(33)34)18-6-4-3-5-7-18)23-14-21(35-2)12-13-25(23)30(17)27(32)19-8-10-20(29)11-9-19/h3-14,24H,15-16H2,1-2H3,(H,33,34)

HIDE SMILES / InChI

Molecular Formula C28H24ClNO6
Molecular Weight 505.946
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/737751 | https://www.ncbi.nlm.nih.gov/pubmed/3907121 | https://www.ncbi.nlm.nih.gov/pubmed/6280733

2-Carboxy-2-Phenylethyl 1-(4-Chlorobenzoyl)-5-Methoxy-2-Methyl-1h-Indole-3-Acetate (Tropesin, VUFB-12018) is indometacin prodrug with potent anti-inflammatory efficacy and advantageous therapeutic properties. In experiments in vivo in rats, after oral administration of a Tropesin dose of 50 mg/kg, esterolysis was observed between 2-3, with a peak level of liberated indometacin between 10-13 h after ingestion. Tropesin was administered orally to rats and dogs in the daily therapeutic dose, triple the dose and ten times the dose for 3 months. After the highest dosage, in isolated cases, some dogs were found to have superficial erosions of the gastric mucosa and dystrophic lesions of renal tubules without biochemical correlations. Indometacin, administered in parallel doses, caused severe lesions of the gastrointestinal tract with melaena and subsequent anemia, as well as severe degenerative changes in renal tubules, in all dosage groups. From the toxicological aspect, Tropesin is substantially more acceptable than indomethacin. The anti-inflammatory and anti-arthritic activities of Tropesin in comparison with indomethacin, were studied in various models of both acute and chronic inflammatory reactions. Both compounds exhibited significant therapeutic activities without substantial quantitative differences.

Originator

Sources: Cesko-Slovenska Farmacie (1977), 26, (6), 232-8.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
[Indomethacin and substance VUFB 12018 (Tropesin SPOFA). A comparison of their side effects on the gastrointestinal tract of rats].
1978 Sep
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Sources: DOI: 10.1007/978-94-010-9423-8_16
Curator's Comment: in rats
Therapeutic dose is 1.4 mg/kg
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:33:38 GMT 2023
Edited
by admin
on Sat Dec 16 08:33:38 GMT 2023
Record UNII
P8NV2308A2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2-CARBOXY-2-PHENYLETHYL 1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOLE-3-ACETATE
Systematic Name English
1H-INDOLE-3-ACETIC ACID, 1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-, 2-CARBOXY-2-PHENYLETHYL ESTER
Systematic Name English
INDOMETACIN TROPIC ACID ESTER
WHO-DD  
Common Name English
TROPESIN [MI]
Common Name English
REPANIDAL
Brand Name English
1H-INDOLE-3-ACETIC ACID, 1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-, 2-CARBOXY-2-PHENYLETHYL ESTER, (±)-
Common Name English
VUFB-12018
Code English
TROPESIN
MI  
Brand Name English
Indometacin tropic acid ester [WHO-DD]
Common Name English
Code System Code Type Description
DRUG CENTRAL
2773
Created by admin on Sat Dec 16 08:33:38 GMT 2023 , Edited by admin on Sat Dec 16 08:33:38 GMT 2023
PRIMARY
PUBCHEM
47530
Created by admin on Sat Dec 16 08:33:38 GMT 2023 , Edited by admin on Sat Dec 16 08:33:38 GMT 2023
PRIMARY
CAS
65828-79-7
Created by admin on Sat Dec 16 08:33:38 GMT 2023 , Edited by admin on Sat Dec 16 08:33:38 GMT 2023
SUPERSEDED
FDA UNII
P8NV2308A2
Created by admin on Sat Dec 16 08:33:38 GMT 2023 , Edited by admin on Sat Dec 16 08:33:38 GMT 2023
PRIMARY
SMS_ID
100000077328
Created by admin on Sat Dec 16 08:33:38 GMT 2023 , Edited by admin on Sat Dec 16 08:33:38 GMT 2023
PRIMARY
EPA CompTox
DTXSID40983767
Created by admin on Sat Dec 16 08:33:38 GMT 2023 , Edited by admin on Sat Dec 16 08:33:38 GMT 2023
PRIMARY
MERCK INDEX
m11227
Created by admin on Sat Dec 16 08:33:38 GMT 2023 , Edited by admin on Sat Dec 16 08:33:38 GMT 2023
PRIMARY Merck Index
EVMPD
SUB14209MIG
Created by admin on Sat Dec 16 08:33:38 GMT 2023 , Edited by admin on Sat Dec 16 08:33:38 GMT 2023
PRIMARY
CAS
65189-78-8
Created by admin on Sat Dec 16 08:33:38 GMT 2023 , Edited by admin on Sat Dec 16 08:33:38 GMT 2023
PRIMARY